Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eventide Healthcare & Life Sciences Fund

+ Add to Watchlist

ETCHX:US

22.40 USD 0.33 1.45%

As of 09:29:30 ET on 02/27/2015.

Snapshot for Eventide Healthcare & Life Sciences Fund (ETCHX)

Year To Date: +8.53% 3-Month: +19.09% 3-Year: - 52-Week Range: 14.19 - 22.73
1-Month: +5.66% 1-Year: +18.08% 5-Year: - Beta vs SPX: 0.86

Mutual Fund Chart for ETCHX

No chart data available.
  • ETCHX:US 22.40
  • 1M
  • 1Y
Interactive ETCHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETCHX

Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.

Inception Date: 12-27-2012 Telephone: 1-866-447-4228
Managers: FINNY GEORGE KURUVILLA
Web Site: www.catalystmutualfunds.com

Fundamentals for ETCHX

NAV (on 2015-02-27) 22.40
Assets (M) (on 2015-02-27) 190.82
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for ETCHX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ETCHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 1.00
Expense Ratio 2.43

Top Fund Holdings for ETCHX

Filing Date: 12/31/2014
Name Position Value % of Total
Bluebird Bio Inc 71,124 6,523,536 4.370%
Veracyte Inc 591,866 5,717,424 3.830%
Tetraphase Pharmaceuticals Inc 139,092 5,523,360 3.700%
Five Prime Therapeutics Inc 163,655 4,418,688 2.960%
Chimerix Inc 106,787 4,299,264 2.880%
Dyax Corp 302,595 4,254,480 2.850%
Agios Pharmaceuticals Inc 34,375 3,851,424 2.580%
Cempra Inc 153,661 3,612,576 2.420%
Medivation Inc 36,267 3,612,576 2.420%
MacroGenics Inc 97,902 3,433,440 2.300%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil